AlanL.EeEpsteinMD

Anatomic Pathology, Clinical Pathology

Professor

Dr. Epstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Usc Keck School Of Medicine
2011 Zonal Avenue, Hmr 205
Los Angeles, CA 90089
Phone+1 818-426-9595

Fax+1 323-442-3049

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 1984 - 1985
Stanford University School of MedicineClass of 1978

PubMed

3 citations
Immune Priming with Spatially Fractionated Radiation Therapy.
Lauren Lukas, Hualin Zhang, Karen Cheng, Alan Epstein
Current Oncology Reports. 2023-12-01
7 citations
Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression.
Jessica A Lapierre, Lauren A Geary, Julie K Jang, Alan L Epstein, Frank Hong
Biochemical and Biophysical Research Communications. 2022-12-17
29 citations
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes.
Qinqin Cheng, Zhefu Dai, Goar Smbatyan, Alan L Epstein, Heinz-Josef Lenz
Molecular Therapy. 2022-09-07

Congress of Clinical Rheumatology Reloaded: West Follows East with Fresh Topics, SpeakersAugust 27th, 2021

Monoclonal Antibodies Against T-Regulatory CellsNational Cancer Institute2004–2005
TNT Imaging To Monitor The Efficacy Of Cancer TherapyNational Cancer Institute2000–2002
Immunotherapy Of Lymphomas With Lym-1 And Lym-2National Cancer Institute1994
Immunotherapy Of Human Lymphomas With Lym-1 And Lym-2National Cancer Institute1992–1993
Tumor Necrosis Treatment Of Human CancerNational Cancer Institute1991–1993
Immunotherapy Of Human Lymphomas W/Lym-1 &Lym-2National Cancer Institute1988–1990
Development And Characterization Of Myeloma Cell LinesNational Cancer Institute1985–1987